Rocatinlimab Effective for Moderate-to-Severe Atopic Dermatitis

THURSDAY, Dec. 15, 2022 -- The anti-OX40 antibody rocatinlimab is effective for adults with confirmed atopic dermatitis with moderate-to-severe disease activity, according to a study published online Dec. 9 in The Lancet.
Emma Guttman-Yassky, M.D.,...